SCHEMBL13079412

SCHEMBL13079412

COc1c(C)c(F)c(OC)c2ccccc12

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.58
ALDH1A1 P00352 3/20 0.58
SMN1; SMN2 Q16637 2/20 0.58
MAPK1 P28482 1/20 0.58
POLB P06746 1/20 0.42
CYP1A2 P05177 3/20 0.42
CYP2C9 P11712 2/20 0.42
IDO1 P14902 2/20 0.42
MCL1 Q07820 1/20 0.37
CYP2C19 P33261 1/20 0.37
AHR P35869 1/20 0.34
ALOX5AP P20292 1/20 0.34
FEN1 P39748 1/20 0.34
TUBB4A P04350 2/20 0.33
TUBB P07437 2/20 0.33
TUBA3C P0DPH7 2/20 0.33
TUBA1B P68363 2/20 0.33
TUBA4A P68366 2/20 0.33
TUBB4B P68371 2/20 0.33
TUBB3 Q13509 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16577909 0.85 KDM4E (0.56) KDM4EALDH1A1SMN1; SMN2MAPK1POLB
SCHEMBL30003417 0.84 KDM4E (0.74) KDM4EALDH1A1SMN1; SMN2MAPK1POLB
SCHEMBL14349080 0.84 KDM4E (0.74) KDM4EALDH1A1SMN1; SMN2MAPK1POLB
SCHEMBL22788818 0.79 KDM4E (0.67) KDM4EALDH1A1SMN1; SMN2MAPK1POLB
SCHEMBL755681 0.77 KDM4E (0.79) KDM4EALDH1A1SMN1; SMN2MAPK1POLB
SCHEMBL30660758 0.77 KDM4E (0.79) KDM4EALDH1A1SMN1; SMN2MAPK1POLB
SCHEMBL13894554 0.76 ALDH1A1 (0.45) KDM4EALDH1A1SMN1; SMN2MAPK1POLB
SCHEMBL52405 0.75 ALDH1A1 (1.00) KDM4EALDH1A1SMN1; SMN2MAPK1POLB
SCHEMBL29366129 0.75 ALDH1A1 (1.00) KDM4EALDH1A1SMN1; SMN2MAPK1POLB
SCHEMBL13393655 0.74 KDM4E (0.58) KDM4EALDH1A1SMN1; SMN2MAPK1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100297113-A1 QUINONE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF PURDUE RESEARCH FOUNDATION 2010-11-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100297113-A1 QUINONE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF APEX1, NQO1, REV1 KDM4E 2642/4885ALDH1A1 210/4885SMN1; SMN2 4316/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.